ACTIVE

FINICOMA

Export PDF

Financial year 2024 · Closed on 30/09/2024

Net result-774,7 k €+69,4 %over 1 year
Revenue2,1 M €+27,4 %over 1 year
Equity2,9 M €+618,1 %over 1 year

Identity

Source · BCE/KBO

FINICOMA is a Private limited company incorporated in 2016. Its main activity is: Management consultancy activities. Its registered office is in Gent.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0668.547.457
Incorporation
29/12/2016
Legal form
Private limited company
Registered office
Herman Teirlinckstraat 15
9041 Gent · FlandreSee on map
Contributed capital
2 747 148,34 €
Latest accounts
30/09/2024
Joint committees (1)
  • 200
Signals
Positive EBITDAHigh revenue

Financials

Source · NBB, 5 filings

Trend over 5 financial years

20242023202220212020
Income statement
Revenue2,1 M €1,7 M €1,7 M €899,5 k €–
EBITDA150 k €-1,1 M €-402,3 k €155,7 k €313 k €
Operating result-22,8 k €-979,8 k €-830,6 k €133 k €280,2 k €
Net result-774,7 k €-2,5 M €324,6 k €-932 k €-6,1 k €
Balance sheet
Equity2,9 M €-560,2 k €2 M €1,6 M €2,6 M €
Total assets83,6 M €41,4 M €27,6 M €14,3 M €15 M €
Cash3,5 M €180,5 k €31,1 k €8,7 k €2,1 k €
Debts80,4 M €41,7 M €25,2 M €12,6 M €11,9 M €
Other
Workforce–––0,3 ETP–

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 30/09/2024

1 active · 2 ended

Active mandates

Ovalie Développement 2 SAS

Director · since 28 juillet 2021 · 0763.877.275

Represented by Jean-Pierre Mahé

Active

Ended mandates

Filip Hoornaert

Director · since 29 décembre 2016 · until 28 juillet 2021

Ended
Filip Hoornaert

Mandate

Ended

Other companies at this address

Herman Teirlinckstraat 15 9041 Gent
CompanyCBE no.
Eqwal● Active
0426.419.720
Eqwal Care● Active
0707.608.763
Eqwal Roeselare● Active
0450.255.093
Eqwal Stomacare● Active
0849.873.517
Nixa-Phone● Liquidation
0827.622.410

Full financial information

Source · NBB
20242023202220212020
Type of accountFull modelFull modelFull modelFull modelAbridged model
Start of the financial year01/10/202301/10/202201/10/202101/01/202101/12/2019
Closing of the financial year30/09/202430/09/202330/09/202230/09/202131/12/2020
Length of the financial year12 months12 months12 months9 months13 months
Filing date14/07/202502/10/202412/05/202317/03/202230/07/2021
General meeting30/06/202530/09/202411/05/202301/03/202230/06/2021
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model30/09/202430/06/202514/07/2025DutchPDF
Full model30/09/202330/09/202402/10/2024DutchPDF
Full model30/09/202211/05/202312/05/2023DutchPDF
Full model30/09/202101/03/202217/03/2022DutchPDF
Abridged model31/12/202030/06/202130/07/2021DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/09/2024

1 active · 2 ended

Active mandates

Ovalie Développement 2 SAS

Director · since 28 juillet 2021 · 0763.877.275

Represented by Jean-Pierre Mahé

Active

Ended mandates

Filip Hoornaert

Director · since 29 décembre 2016 · until 28 juillet 2021

Ended
Filip Hoornaert

Mandate

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates11/06/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring16/05/2025
    KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring26/03/2025
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates05/12/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring26/06/2024
    KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring15/03/2024
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates30/08/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates29/03/2022
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 30/09/2024
    reconductionRSM INTERAUDIT BV — commissaris
  2. 2024
    Annual accounts 2024-774,7 k €↑
  3. 23/04/2024
    apport
  4. 2023
    Annual accounts 2023-2,5 M €↓
  5. 2022
    Annual accounts 2022324,6 k €↑
  6. 2021
    Annual accounts 2021-932 k €↓
  7. 2020
    Annual accounts 2020-6,1 k €
  8. 29/12/2016
    IncorporationPrivate limited company